Government launches mobile app to show drug prices

hanumThe Union Minister of Chemicals & Fertilizers Ananth Kumar launched a mobile app to help buyers find the correct price of medicines.

Called ‘Pharma Sahi Daam’- the app shows the maximum retail price fixed by National Pharmaceutical Pricing Authority (NPPA) for various scheduled drugs on real time basis.

On the occassion of NPPA Foundation Day, the Minister appealed to the industry leaders, state governments and other departments in pooling efforts to make available medicines at affordable prices to the common man.

¨In the last two and a half years, almost 900 formulations have been brought under the price control, providing a saving of about 5000 crores to the consumers. National Pharmaceutical Pricing Authority (NPPA) has already come out with ceiling price of 368 new drugs within 6 months of the issue of New National List of Essential Medicines-2015¨ he further added.

The Minister said that he is pursuing the case for making an independent Ministry for Pharmaceuticals so that all decisions regarding the industry could be taken under a single roof.

The pharmaceutical industry has risen to almost $37 billion and Indian medicines are being exported to over 200 countries. Pharmaceuticals is a sunrise industry and the Government is keen to provide support to it through various means like pharmaceutical parks, medical devices parks, pharmaceutical clusters and promotion of innovation through Atal Innovation Scheme, he added.

A strategy is being adopted to provide cheap medicines to the common man- one is through regulating the prices by NPPA and another is opening of PM Jan Aushadhi Stores. He said that within one year, 3000 PM Jan Aushadhi Stores will be opened in the country covering all districts and administrative divisions.

The Minister further said that most of the medicines in Jan Aushadhi stores cost 30 to 40 per cent as compared to the market cost and no medicine in Jan Aushadhi Store is more than 50 per cent of the market cost.



Govt of India starts crack down on low-quality medicine makers The government of India has started conducting inspections at drug manufacturing units across the country to prevent the production of low-quality drugs and medicines in India.Typically, inspections are conducted by state authorities, while central agencies largely confine themselves to checking quality of final products put up on store shelves.H...
Cipla redraws Iran plans with new agreement, to invest Rs 121 cr Cipla said its wholly owned subsidiary of the Company in Netherlands will set up a 75% joint venture with Ahran Tejarat Company for manufacturing and marketing of pharmaceutical products in Iran.An earlier agreement executed by the Company with the Iranian firm has been terminated.The total investment will be euro 16.875 million, which comes to about...
Allahabad High Court says Triple Talaq ‘unconstitutional’ The Allahabad High Court has today said 'triple talaq' or the divorcing of women under Islamic laws -- is unconstitutional in Indian law.The provision "violates women's rights" and no personal law board is above the Indian constitution, the court said while hearing a petition filed by a Muslim woman from Bulandshahr.The constitution of India assu...
7 ILLOGICAL REASONS to oppose DEMONETIZATION The current demonetization move by the Narendra Modi government has seen a lot of accusations and counter-accusations being levelled by both the supporters and opponents of the move.While the government has tried to deal head on with the official accusations levelled by opposition political parties, a much more subtle misinformation campaign is going o...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS primarily develops, manufactures and markets products across various therapeuti...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta tablets of Boehringer Ingelheim Pharmaceuticals, Inc.An Abbreviated New Drug ...
Minister refuses to answer Parliament on amendment to anti-corruption bill The ministry of personnel, public grievances and pensions has refused to provide an answer to the Parliament on whether the proposed amendment to the Prevention of Corruption Act will make investigation of corruption charges against officials difficult.The ministry -- which oversees all administrative matters relating to central government employees ...
40% of High Court judge positions are vacant, 30% in trial courts A large proportion of the posts for judges in the various High Courts in India are lying vacant, resulting in painfully slow dispensation of justice, according to law ministry numbers.Out of a total of 1079 posts of judges in all the High Courts in India, a whopping 442 are lying vacant as of last week. This translates to a vacancy of 41% in the High Cou...
Lupin launches injectable iron formulations in India Pharma major Lupin Limited said it launched Iron Isomaltoside injectable iron formulation under two brand names “Isofer” and “Jilazo” in India.Lupin acquired the exclusive rights to market, distribute and sell the injectable formulation from Denmark based Pharmacosmos A/S.The product is currently marketed in 33 countries, including 21 European Union coun...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, r...
RPP Infra Projects wins Rs 254 mln contract from TN Civil Supplies RPP Infra projects Ltd said it received a contract worth Rs 254 mln from Tamil Nadu Civil Supplies Corporation to construct scientific storage godown at Kodavasal village & taluk in Thiruvarur district.The godown is of 2500 MT and is to be completed within 24 months.R.P.P Infra Projects Ltd, founded in 1988, is a construction company located at E...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being developed to commercialize in Indian and international markets.A serotype is a...
Aarti Industries to return Rs 96 cr to shareholders via buyback Speciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr.The company´s Board of Directors approved the equity shares -- representing up to 1.44% of the company's base."The public announcement setting out the process, timelines and other requisite detail will be released in du...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in the body. Paricalcitol Capsules are therapeutically equivalent to the reference l...
India overdependent on China for medicines – study India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an "overwhelming dependence" on China for the raw material required to produce these drugs, industry association Assocham said.Indian companies depend on China to supply them with the main raw material in drug making -- known as Active Pharmaceuti...